09.10.2013 Views

Dermatologic Differential Diagnosis.pdf. - Famona Site

Dermatologic Differential Diagnosis.pdf. - Famona Site

Dermatologic Differential Diagnosis.pdf. - Famona Site

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Alprazolam (Xanax) – phototoxic JAAD 40:832–833, 1999;<br />

<strong>Dermatologic</strong>a 181:75, 1990<br />

Amantidine – UVA Contact Dermatitis 9:165, 1983<br />

Amiodarone – UVA Ann Pharmacother 34:1075, 2000;<br />

Circulation 92:1665, 1995; Acta DV 67:76–79, 1987;<br />

BJD 115:253–254, 1986; AD 120:1591–1594, 1984;<br />

BJD 110:451–456, 1984<br />

Amitryptiline Am J Hematol 53:49–50, 1996<br />

Amlodipine – photo-induced telangiectasia<br />

BJD 142:1255–1256, 2000<br />

Ampicillin<br />

Ampiroxicam Dermatology 195:409–410, 1997; Contact<br />

34:298–299, 1996<br />

Antidepressants<br />

Antifungals (topical)<br />

Jadit Med J Aust 1 (13):651–652, 1973; BJD 82:224–229, 1970<br />

Multifungin AD 95:287–291, 1967<br />

Fentichlor AD 95:287–291, 1967<br />

Argyria – slate-gray pigmentation of sun-exposed areas<br />

(forehead, nose, hands) Am J Kidney Dis 37:1048–1051, 2001;<br />

BJD 104:19–26, 1981; AD 114:373–377, 1978<br />

Arsenic Ghatan p.255, 2002, Second Edition<br />

Aspirin – UVA<br />

Atabrine (mepacrine) – greenish–yellow pigmentation of face,<br />

hands, feet; then diffuse Am J Med Sci 192:645–650, 1936<br />

Atenelol-induced lupus erythematosus JAAD 37:298–299, 1997<br />

Azeperone – UVA<br />

Azapropazone<br />

Azathioprine – pellagrous dermatitis JAAD 46:597–599, 2002<br />

Bendroflumethiazide – UVA<br />

Benoxaprofen (NSAID) – UVA and UVB; persistent<br />

photosensitivity BJD 121:551–562, 1989; BJD 115:515–516,<br />

1986; JAAD 7:689–690, 1982; photo-onycholysis<br />

JAAD 7:678–680, 1982<br />

Benzidamine hydrochloride (NSAID) – UVA<br />

Benzocaine – photocontact allergy AD 117:77–79, 1981<br />

Benzodiazepines – UVB<br />

Beta blockers<br />

Calcipotriene and UVB AD 131:1305–1307, 1995<br />

Calcium channel blockers – felodipine, nifedipine, amlodipine,<br />

diltiazem – photodistributed telangiectasias JAAD 45:323–324,<br />

2001; BJD 136:974–975, 1997; J Allergy Clin Immunol<br />

97:852–855, 1996<br />

Capecitabine (Xeloda) JAAD 47:453, 2002<br />

Captopril – including drug-induced SCLE Lancet 345:398, 1995;<br />

LE-like Ann DV 115:167–169, 1988; Acta DV 65:447–448, 1985<br />

Carbamazepine – pellagrous dermatitis JAAD 46:597–599, 2002<br />

Carprofen – UVA<br />

Cefazolin – photo-recall reaction Cutis 73:79–80, 2004<br />

Ceftazidime Lancet 341 (8854):1221–1222, 1993<br />

Cetuximab – seborrheic dermatitis-like eruption J Clin Oncol<br />

18:904–914, 2000<br />

Chloramphenicol – pellagrous dermatitis JAAD 46:597–599, 2002<br />

Chlordiazepoxide AD 91:362–363, 1965<br />

Chloroquine AD 118:290, 1982; phototoxicity leading to vitiligo<br />

J R Army Med Corps 144:163–165, 1998<br />

Chlorpromazine – phototoxicity and photoallergy<br />

AD 98:354–363, 1968; lichenoid dermatitis <strong>Dermatologic</strong>a<br />

PHOTOERUPTION AND/OR SEBORRHEIC DERMATITIS-LIKE ERUPTION 509<br />

159:46–49, 1979; immediate and delayed photoallergy<br />

AD 111:1469–1471, 1975<br />

Chlorpropamide <strong>Dermatologic</strong>a 146:25–29, 1973 Chlorthiazide<br />

Chrysotherapy – drug-induced SCLE JAAD 35:147–169, 1996;<br />

gold (chrysiasis) – slate-blue hyperpigmentation around the eyes<br />

and in sun-exposed areas JAAD 39:524–525, 1998; oral gold<br />

therapy with laser therapy AD 131:1411–1414, 1995; seborrheic<br />

dermatitis-like eruption Ghatan p.23, 2002, Second Edition<br />

Cilazapril-induced SCLE Lancet 345:398, 1995<br />

Cimetidine – seborrheic dermatitis-like eruption AD 117:65–66,<br />

1981<br />

Cinchocaine (dibucaine) – photocontact dermatitis Contact<br />

Dermatitis 39:139–140, 1998<br />

Cinnarizine – drug-induced SCLE Lupus 7:364–366, 1998<br />

Ciprofloxacin – photo-recall JAAD 44:1054–1058, 2001<br />

Clinoril<br />

Clioquinol<br />

Clomipramine Am J Psychiatry 146:552–553, 1989<br />

Clobazam – photo-induced TEN BJD 135:999–1002, 1996<br />

Clorazepate dipotassium – photo-onycholysis JAAD<br />

21:1304–1305, 1989<br />

Clozapine J Clin Psychiatry 56:589, 1995<br />

COL-3 – non-antibiotic tetracycline derivative anti-cancer<br />

agent – drug-induced lupus erythematosus<br />

AD 137:471–474, 2001<br />

Corticosteroids – steroid perioral dermatitis<br />

Dacarbazine – UVA/?UVB – phototoxicity JAAD 50:783–785,<br />

2004; JAAD 40:367–398, 1999; Photodermatol 6:140–141,<br />

1989; JAAD 4:541–543, 1981<br />

Dapsone Eur J Dermatol 11:50–53, 2001; Z Hautkr 63:53–54,<br />

1988 (German); Lepr Rev 58:425–428, 1987<br />

Demeclocycline – phototoxic and photolichenoid eruptions<br />

AD 109:97–98, 1974<br />

Dermatomyositis-like drug reaction<br />

BCG Scand J Rheumatol 8:187–191, 1979<br />

Carbamazepine Br Med J ii:1434, 1966<br />

Hydroxyurea – acral dermatomyositis lesions<br />

JAAD 21:797–799, 1989<br />

NSAIDS (niflumic acid and diclofenac) <strong>Dermatologic</strong>a<br />

178:58–59, 1989<br />

Penicillamine J Rheumatol 14:997–1001, 1987<br />

Desipramine – blue–gray photo-pigmentation AD 129:474–476,<br />

1993<br />

Desoximetasone – UVA<br />

Diazepam<br />

Diflunisal – UVA – lichenoid photoreactive epidermal necrosis<br />

JAAD 20:850–851, 1989<br />

Diltiazem JAAD 38:201–206, 1998; reticulated, blue–gray,<br />

photodistributed hyperpigmentation AD 137:179–182, 2001;<br />

drug-induced SCLE Hum Pathol 28:67–73, 1997<br />

Diphenhydramine – UVB AD 110:249–252, 1974; photoallergic<br />

contact dermatitis Contact Dermatitis 38:282, 1998<br />

Doxepin cream JAAD 34:143–144, 1996<br />

Doxycycline Rook p.1960, 1998, Sixth Edition; Contact<br />

Dermatitis 37:93–94, 1997; Clin Exp Dermatol 18:425–427,<br />

1993; papular photosensitivity AD 108:837–838, 1973;<br />

photo-onycholysis Rook p.1960, 1998, Sixth Edition<br />

D-penicillamine JAAD 35:147–169, 1996<br />

Droxicam Int J Dermatol 36:318–320, 1997<br />

Efavirenz – in HIV disease JAAD 49:159–160, 2003;<br />

AIDS 15:1085–1086, 2001

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!